Manufacturer
DUOPHARMA (M) SDN. BHD.
Contents
Medroxyprogesterone acetate
Indication
Palliative treatment of endometrial and renal carcinoma,Mild to moderate endometriosis,Breast cancer,Progestogen component in menopausal hormonal replacement therapy, Menorrhagia, Palliative treatment of prostatic carcinoma, Secondary amenorrhoea.
Instruction
May be taken with or without food. Incidence of minor indigestion may increase as dose increases. Take w/ meals if necessary.
Drug interaction
Aminoglutethimide and enzyme-inducing drugs (e.g. carbamazepine, griseofulvin, phenobarbital, rifampicin, phenytoin) may reduce plasma concentrations leading to reduced efficacy. Additional measures required when medroxyprogesterone is used for contraception during coadministration with these drugs.
Malaysia
